» Authors » Vasil Peev

Vasil Peev

Explore the profile of Vasil Peev including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 528
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mossack S, Spellman A, Lagalbo S, Santos C, Peev V, Saltzberg S, et al.
Cureus . 2024 May; 16(4):e58556. PMID: 38765422
Background Current literature suggests that anywhere from 2.9-27% of renal transplant recipients (RTR) will develop recurrent urinary tract infections (UTIs) (≥2 UTIs over six months or ≥3 UTIs over 12...
2.
Santos C, Rhee Y, Hollinger E, Olaitan O, Schadde E, Peev V, et al.
Clin Transplant . 2021 May; 35(8):e14362. PMID: 33998716
Background: COVID-19 epidemiologic studies comparing immunosuppressed and immunocompetent patients may provide insight into the impact of immunosuppressants on outcomes. Methods: In this retrospective cohort study, we assembled kidney or kidney-pancreas...
3.
Shaefi S, Brenner S, Gupta S, OGara B, Krajewski M, Charytan D, et al.
Intensive Care Med . 2021 Feb; 47(2):208-221. PMID: 33528595
Purpose: Limited data are available on venovenous extracorporeal membrane oxygenation (ECMO) in patients with severe hypoxemic respiratory failure from coronavirus disease 2019 (COVID-19). Methods: We examined the clinical features and...
4.
Sousanieh G, Whittier W, Rodby R, Peev V, Korbet S
Am J Nephrol . 2021 Jan; 51(12):982-987. PMID: 33454708
Background: As percutaneous renal biopsies (PRBs) are increasingly performed by radiologists, an increase in the use of 18-gauge automated needle stands to compromise adequacy. We compare the adequacy and safety...
5.
Koh K, Cao Y, Mangos S, Tardi N, Dande R, Lee H, et al.
J Clin Invest . 2019 Feb; 129(4):1713-1726. PMID: 30747722
Soluble urokinase receptor (suPAR) is a circulatory molecule that activates αvβ3 integrin on podocytes, causes foot process effacement, and contributes to proteinuric kidney disease. While active integrin can be targeted...
6.
Wei C, Li J, Adair B, Zhu K, Cai J, Merchant M, et al.
J Clin Invest . 2019 Feb; 129(5):1946-1959. PMID: 30730305
Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived circulating signaling molecule that has been implicated in chronic kidney disease, such as focal segmental glomerulosclerosis (FSGS). Typically, native uPAR (isoform...
7.
Hayek S, Koh K, Grams M, Wei C, Ko Y, Li J, et al.
Nat Med . 2017 Jun; 23(8):945-953. PMID: 28650456
Soluble urokinase plasminogen activator receptor (suPAR) independently predicts chronic kidney disease (CKD) incidence and progression. Apolipoprotein L1 (APOL1) gene variants G1 and G2, but not the reference allele (G0), are...
8.
Dande R, Peev V, Altintas M, Reiser J
J Diabetes Res . 2017 Jun; 2017:3232848. PMID: 28596971
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD) worldwide. DN typically manifests by glomerular hyperfiltration and microalbuminuria; then, the disease progresses to impaired glomerular filtration rate,...
9.
Hahm E, Peev V, Reiser J
Cell Tissue Res . 2017 Jun; 369(1):211-216. PMID: 28560690
The kidney is an organ involved in cross talk with many human organs. The link between the immune system and the kidney has been studied in some detail, although data...
10.
Peev V, Hahm E, Reiser J
F1000Res . 2017 May; 6:466. PMID: 28491286
Focal segmental glomerulosclerosis (FSGS) represents the most common primary glomerular disease responsible for the development of end-stage renal disease (ESRD) in the United States (US). The disease progresses from podocyte...